PMID- 22850733 OWN - NLM STAT- MEDLINE DCOM- 20130322 LR - 20211021 IS - 1740-634X (Electronic) IS - 0893-133X (Print) IS - 0893-133X (Linking) VI - 37 IP - 12 DP - 2012 Nov TI - Investigation of cortical glutamate-glutamine and gamma-aminobutyric acid in obsessive-compulsive disorder by proton magnetic resonance spectroscopy. PG - 2684-92 LID - 10.1038/npp.2012.132 [doi] AB - Glutamatergic abnormalities in corticostriatal brain circuits are thought to underlie obsessive-compulsive disorder (OCD). Whether these abnormalities exist in adults with OCD is not clear. We used proton magnetic resonance spectroscopy ((1)H MRS) to test our hypothesis that unmedicated adults with OCD have reduced glutamate plus glutamine (Glx) levels in the medial prefrontal cortex (MPFC) compared with healthy controls. Levels of gamma-aminobutyric acid (GABA) were also explored. Twenty-four unmedicated adults with OCD and 22 matched healthy control subjects underwent (1)H MRS scans at 3.0 T. Resonances of both Glx and GABA were obtained using the standard J-editing technique and assessed as ratios relative to voxel tissue water (W) in the MPFC (the region of interest) and the dorsolateral prefrontal cortex (DLPFC) to explore the regional specificity of any finding. In the MPFC, Glx/W did not differ by diagnostic group (p=0.98) or sex (p=0.57). However, GABA/W was decreased in OCD (2.16+/-0.46 x 10(-)(3)) compared with healthy controls (2.43+/-0.45 x 10(-)(3), p=0.045); moreover, age of OCD onset was inversely correlated with MPFC GABA/W (r=-0.50, p=0.015). MPFC GABA/W was higher in females than in males. In the DLPFC, there were no main effects of diagnosis or gender on Glx/W or GABA/W. These data indicate that unmedicated adults with OCD do not have Glx abnormalities in a MPFC voxel that includes the pregenual anterior cingulate cortex. However, they may have decreased MPFC GABA levels. How GABA abnormalities might contribute to corticostriatal dysfunction in OCD deserves further study. FAU - Simpson, Helen B AU - Simpson HB AD - Department of Psychiatry at Columbia University, College of Physicians and Surgeons, New York, NY 10032, USA. simpson@nyspi.columbia.edu FAU - Shungu, Dikoma C AU - Shungu DC FAU - Bender, James Jr AU - Bender J Jr FAU - Mao, Xiangling AU - Mao X FAU - Xu, Xiaoyan AU - Xu X FAU - Slifstein, Mark AU - Slifstein M FAU - Kegeles, Lawrence S AU - Kegeles LS LA - eng GR - K24 MH091555/MH/NIMH NIH HHS/United States GR - R01 MH073915/MH/NIMH NIH HHS/United States GR - R01 MH075895/MH/NIMH NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20120801 PL - England TA - Neuropsychopharmacology JT - Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology JID - 8904907 RN - 0RH81L854J (Glutamine) RN - 3KX376GY7L (Glutamic Acid) RN - 56-12-2 (gamma-Aminobutyric Acid) SB - IM MH - Adolescent MH - Adult MH - Age of Onset MH - Brain Chemistry/physiology MH - Cerebral Cortex/*metabolism/*pathology MH - Data Interpretation, Statistical MH - Diagnostic and Statistical Manual of Mental Disorders MH - Female MH - Glutamic Acid/*metabolism MH - Glutamine/*metabolism MH - Humans MH - Image Processing, Computer-Assisted MH - Magnetic Resonance Imaging MH - Magnetic Resonance Spectroscopy MH - Male MH - Middle Aged MH - Obsessive-Compulsive Disorder/*metabolism/*pathology/psychology MH - Young Adult MH - gamma-Aminobutyric Acid/*metabolism PMC - PMC3473334 EDAT- 2012/08/02 06:00 MHDA- 2013/03/23 06:00 PMCR- 2013/11/01 CRDT- 2012/08/02 06:00 PHST- 2012/08/02 06:00 [entrez] PHST- 2012/08/02 06:00 [pubmed] PHST- 2013/03/23 06:00 [medline] PHST- 2013/11/01 00:00 [pmc-release] AID - npp2012132 [pii] AID - 10.1038/npp.2012.132 [doi] PST - ppublish SO - Neuropsychopharmacology. 2012 Nov;37(12):2684-92. doi: 10.1038/npp.2012.132. Epub 2012 Aug 1.